Evolution of the Average Target: BioNTech SE

Data source: BioNTech SE(BNTX)
Evolution of the Average Target - BioNTech SE

Evolution of the Target Price: BioNTech SE

Data source: BioNTech SE(BNTX)
Evolution of the Target Price - BioNTech SE

Changes in Analyst Recommendations: BioNTech SE

Data source: BioNTech SE(BNTX)
5153d07a1417c1383a8f61c73a28bde5.H2xKyMW2mvHcLP7ri1OqHsqPwo0r-BpBcFhKTp0BNvA.dVs55fH56bO3W4yuzz3aUPPJmvVdgi4WCg0IAvlgX6hYJRqKtdLYwo5Dqw~ecf504cff7ac5f053fc1a435a62c9713
10-27 BioNTech SE : JP Morgan gives a Neutral rating ZD
10-26 BioNTech SE : UBS reiterates its Buy rating ZD
10-09 BofA Adjusts Price Target on BioNTech to $114 From $122, Keeps Buy Rating MT
10-08 Argus Research Initiates Coverage on BioNTech SE With Hold Rating MT
10-07 BioNTech SE : Gets a Buy rating from Berenberg ZD
09-16 Berenberg Raises Price Target on BioNTech to $140 From $132, Keeps Buy Rating MT
09-16 BioNTech SE : UBS maintains a Buy rating ZD
09-16 BioNTech SE : Jefferies keeps its Buy rating ZD
09-16 BioNTech SE : Berenberg gives a Buy rating ZD
09-15 BioNTech SE : Jefferies maintains a Buy rating ZD
09-08 BMO Capital Downgrades BioNTech to Market Perform From Outperform, Adjusts PT to $105 From $128 MT
09-04 BioNTech SE : Goldman Sachs gives a Buy rating ZD
08-28 Germany's DAX Index Extends Gains; BioNTech Tumbles After Scrapping Cancer Vaccine Trial MT
08-26 BioNTech SE : Deutsche Bank reiterates its Buy rating ZD
08-20 Cancer vaccines finally garner the spotlight Alphavalue
08-20 BioNTech SE : Jefferies keeps its Buy rating ZD
08-05 Berenberg Bank Adjusts BioNTech SE Price Target to $132 From $140, Maintains Buy Rating MT
08-05 BIONTECH : Berenberg reiterates its Buy rating ZD
08-04 BIONTECH : Gets a Buy rating from Jefferies ZD
08-04 BIONTECH : Bernstein sticks Neutral ZD
08-04 BioNTech: Q2 miss, followed by a sales guidance downgrade Alphavalue
08-04 Wall Street Bets on the Magnificent Seven Again Zonebourse
07-14 Where would AI lead Pharma in the long run? Alphavalue
07-08 Morgan Stanley Adjusts Price Target BioNTech to $119 From $126, Maintains Overweight Rating MT
06-01 BIONTECH : Buy rating from Jefferies ZD

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+41.72%
+26.36%
+10.61%
+10.61%
+16.9%
+37.16%
+42.61%
-17.48%
+30.19%
Average +22.07%
Weighted average by Cap. +22.71%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
78.94EUR
Average target price
104.16EUR
Spread / Average Target
+31.94%
High Price Target
128.59EUR
Spread / Highest target
+62.89%
Low Price Target
67.87EUR
Spread / Lowest Target
-14.03%

Analyst Consensus Detail

Analyst consensus - BioNTech SE

Consensus revision (last 18 months)

Consensus revision (last 18 months) - BioNTech SE
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - BioNTech SE